Predicting Prognosis of Early-Stage Mycosis Fungoides with Utilization of Machine Learning

被引:0
|
作者
Mendi, Banu Ismail [1 ]
Sanli, Hatice [2 ]
Insel, Mert Akin [3 ]
Aydemir, Beliz Bayindir [2 ]
Atak, Mehmet Fatih [4 ]
机构
[1] Nigde Omer Halisdemir Univ Training & Res Hosp, Dept Dermatol, TR-51000 Nigde, Turkiye
[2] Ankara Univ, Fac Med, Dept Hematol, TR-06620 Ankara, Turkiye
[3] Yildiz Tech Univ, Dept Chem Engn, Istanbul 34220, Turkiye
[4] New York Med Coll, Dept Dermatol, Valhalla, NY 10595 USA
来源
LIFE-BASEL | 2024年 / 14卷 / 11期
关键词
machine learning; mycosis fungoides; prognosis; FOLD CROSS-VALIDATION; LYMPHOMA TASK-FORCE; SEZARY-SYNDROME; INTERNATIONAL-SOCIETY; EUROPEAN-ORGANIZATION; CUTANEOUS-LYMPHOMAS; COX REGRESSION; UNITED-STATES; INDEX CLIPI; SURVIVAL;
D O I
10.3390/life14111371
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mycosis fungoides (MF) is the most prevalent type of cutaneous T cell lymphomas. Studies on the prognosis of MF are limited, and no research exists on the potential of artificial intelligence to predict MF prognosis. This study aimed to compare the predictive capabilities of various machine learning (ML) algorithms in predicting progression, treatment response, and relapse and to assess their predictive power against that of the Cox proportional hazards (CPH) model in patients with early-stage MF. The data of patients aged 18 years and over who were diagnosed with early-stage MF at Ankara University Faculty of Medicine Hospital from 2006 to 2024 were retrospectively reviewed. ML algorithms were utilized to predict complete response, relapse, and disease progression using patient data. Of the 185 patients, 94 (50.8%) were female, and 91 (49.2%) were male. Complete response was observed in 114 patients (61.6%), while relapse and progression occurred in 69 (37.3%) and 54 (29.2%) patients, respectively. For predicting progression, the Support Vector Machine (SVM) algorithm demonstrated the highest success rate, with an accuracy of 75%, outperforming the CPH model (C-index: 0.652 for SVM vs. 0.501 for CPH). The most successful model for predicting complete response was the Ensemble model, with an accuracy of 68.89%, surpassing the CPH model (C-index: 0.662 for the Ensemble model vs. 0.543 for CPH). For predicting relapse, the decision tree classifier showed the highest performance, with an accuracy of 78.17%, outperforming the CPH model (C-index: 0.782 for the decision tree classifier vs. 0.505 for CPH). The results suggest that ML algorithms may be useful in predicting prognosis in early-stage MF patients.
引用
收藏
页数:20
相关论文
共 50 条
  • [41] Comparison of the efficacy of treatment with clobetasol propionate or bexarotene in early-stage mycosis fungoides
    Cerman, Asli Aksu
    Cetinkaya, Pinar Ozdemir
    Kurt, Birgul Ozkesici
    Kirker, Artun
    Altunay, Ilknur
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2025, 100 (02) : 237 - 242
  • [42] The Overlap of Skin and Blood T-Cell Clones in Early-Stage Mycosis Fungoides
    Joffe, Daniel
    Banner, Lauren
    Bhatti, Safiyyah
    Gleason, Laura
    Mandel, Jenna
    Porcu, Pierluigi
    Nikbakht, Neda
    BLOOD, 2023, 142
  • [43] Efficacy of narrowband ultraviolet B and psoralen-ultraviolet A for early-stage mycosis fungoides
    Rooke, B.
    Lovgren, M. -L.
    Yoo, J.
    Shah, F.
    Scarisbrick, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 : 40 - 40
  • [44] The overlap of skin and blood T-cell clones in early-stage mycosis fungoides
    Joffe, Daniel
    Bhatti, Safiyyah
    Banner, Lauren
    Zaya, Romsin
    Gleason, Laura
    Mishra, Anjali
    Kirsch, Ilan
    Porcu, Pierluigi
    Nikbakht, Neda
    BLOOD ADVANCES, 2023, 7 (20) : 6206 - 6210
  • [45] A chart review of patients with early-stage mycosis fungoides treated with psoralen plus ultraviolet A
    Antoniou, C.
    Nikoloau, V.
    Siakantaris, M.
    Bamia, C.
    Stratigos, A.
    Stavrianeas, N.
    Katsambas, A.
    Papadavid, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (02) : 218 - 219
  • [46] The overlap of skin and blood T-cell clones in early-stage mycosis fungoides
    Nikabakht, Neda
    Joffe, Daniel
    Banner, Lauren
    Bhatti, Safiyyah
    Gleason, Laura
    Kirsch, Ilan
    Porcu, Pierluigi
    EUROPEAN JOURNAL OF CANCER, 2023, 190 : S16 - S16
  • [47] Retinoic acid receptor agonist as monotherapy for early-stage mycosis fungoides: does it work?
    Amitay-Laish, Iris
    Reiter, Ofer
    Prag-Naveh, Hadas
    Kershenovich, Ruben
    Hodak, Emmilia
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2019, 30 (03) : 258 - 263
  • [48] Chlormethine Treatment Effectively Targets the Tumor MicroEnvironment in Early-stage Mycosis Fungoides Patients
    Wind, S.
    Rijneveld, R.
    Grievink, H.
    Niemeyer-van der Kolk, T.
    Schrader, A. -R.
    Jansen, P.
    de Miranda, N.
    Ijsselsteijn, M. E.
    Chevalier, M.
    Tomljanovic, I.
    Quint, K.
    Rissmann, R.
    Vermeer, M.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S67 - S68
  • [49] Interstitial fluid immunophenotyping of early-stage mycosis fungoides patients after chlormethine treatment
    Wind, Selinde
    Rijneveld, Rianne
    Grievink, Hendrika
    Mergen, Catherine
    Quint, Koen
    Vermeer, Maarten
    Rissmann, Robert
    EUROPEAN JOURNAL OF CANCER, 2023, 190 : S3 - S3
  • [50] Application of urine proteomics in the diagnosis and treatment effectiveness monitoring of early-stage Mycosis Fungoides
    Song, Hongbin
    Hu, Zhonghui
    Zhang, Shiyu
    Yang, Lu
    Feng, Jindi
    Lu, Lu
    Liu, Yuehua
    Wang, Tao
    CLINICAL PROTEOMICS, 2024, 21 (01)